Sze Men Choi

1.4k citations
9 papers · 486 indexed · h-index 7
Topics
Inflammasome and immune disorders (3 papers)Cell death mechanisms and regulation (2 papers)Immune Response and Inflammation (2 papers)

In The Last Decade

Sze Men Choi

9 papers receiving 482 citations

Peers

Sze Men Choi
Comparison fields: 5 of 78
  • Molecular Biology 340
  • Immunology 183
  • Cancer Research 74
  • Pulmonary and Respiratory Medicine 72
  • Epidemiology 70
Replace Sylvia Torres-Odio with:
Sylvia Torres-Odio United States
Yingchao Hu China
Christian Pröpper Germany
Andrew B. Caldwell United States
Lars Steinmüller Germany
Gareth S. D. Purvis United Kingdom
Christine R. Keenan Australia
Hiroyuki Kunimoto Japan
Xiaoxiao Mao China
Sze Men Choi relative to Sylvia Torres-Odio United States Sylvia Torres-Odio's profile →
Citations per field
00.5×10×15×21.5×
Sylvia Torres-Odio · 1×
Citations per year

Countries citing papers authored by Sze Men Choi

Since Specialization
Citations

This map shows the geographic impact of Sze Men Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sze Men Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sze Men Choi more than expected).

Fields of papers citing papers by Sze Men Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sze Men Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sze Men Choi. The network helps show where Sze Men Choi may publish in the future.

Co-authorship network of co-authors of Sze Men Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Sze Men Choi. A scholar is included among the top collaborators of Sze Men Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sze Men Choi. Sze Men Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 2
2 6
3 52
4 30
5 24
6 99
7 12
8 125
9 136

About Sze Men Choi

Sze Men Choi is a scholar working on Molecular Medicine, Cancer Research and Immunology, having authored 9 papers that have together received 486 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (3 papers), Cell death mechanisms and regulation (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (183 citations), Molecular Biology (340 citations) and Cancer Research (74 citations). Sze Men Choi has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Tom Vanden Berghe, Peter Vandenabeele, Marnik Vuylsteke, Elien Van Wonterghem, Ria Roelandt, Seth W. Perry, Samya Van Coillie, Paco Hulpiau, Roosmarijn E. Vandenbroucke and Liesbet Martens. Their work appears in journals such as Immunity, Molecular Cell and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026